throbber
UNITED STATES PATENT AND TRADEMARK OFFICE
`
`
`
`
`
`
`
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`
`
`
`
`
`
`
`
`COALITION FOR AFFORDABLE DRUGS VII LLC,
`Petitioner,
`
`v.
`
`POZEN INC.,
`Patent Owner.
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`IPR2015-01718
`Patent 8,945,621
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`PETITIONER’S UPDATED EXHIBIT LIST
`
`
`
`

`
`Pursuant to 37 C.F.R. § 42.63(e), Petitioner submits the following current
`
`IPR2015-01718
`Patent 8,945,621
`
`
`
`
`Exhibit List:
`
`Exhibit No. Description
`
`1001
`
`1002
`
`1003
`
`1004
`
`1005
`
`1006
`
`1007
`
`1008
`
`1009
`
`1010
`
`1011
`
`U.S. Patent No. 8,945,621 (“the ’621 Patent”)
`
`File History of the ’621 Patent, U.S. Patent App. No. 12/822,612
`(“the ’612 Application”)
`
`Declaration of Leon Shargel, Ph.D., R.Ph.
`
`U.S. Patent No. 6,926,907 (“Plachetka”)
`
`“Ulcer Prevention in Long-term Users of Nonsteroidal Anti-
`inflammatory Drugs,” David Y. Graham, et al., Archives of
`Internal Medicine, Vol. 162, January 28, 2002
`
`“Ulcer Recurrence in High-Risk Patients Receiving Nonsteroidal
`Anti-Inflammatory Drugs Plus Low-Dose Aspirin: Results of a
`Post Hoc Subanalysis,” Jay L. Goldstein, et al., Clinical
`Therapeutics, Vol. 26, No. 10, October 2004
`
`“Horizon Pharma Announces Agreement to Acquire U.S. Rights
`to VIMOVO(R) and Provides 2014 Guidance,” Horizon Pharma
`(Nov. 19, 2013)
`
`Horizon Pharma plc 2014 Irish Statutory Accounts, Horizon
`Pharma Public Limited Company (Apr. 9, 2015)
`
`“Pharmaceutical Companies Buy Rivals’ Drugs, Then Jack Up
`the Prices,” The Wall Street Journal (Apr. 26, 2015)
`
`U.S. Patent No. 4,757,060
`
`“The Mechanism of Action of Aspirin,” J.R. Vane, et al.,
`Pergamon (June 15, 2003)
`
`1012
`
`G.B. Patent No. 1211134
`
`1
`
`

`
`
`
`Exhibit No. Description
`
`IPR2015-01718
`Patent 8,945,621
`
`
`1013
`
`1014
`
`1015
`
`1016
`
`1017
`
`1018
`
`1019
`
`1020
`
`1021
`
`1022
`
`1023
`
`1024
`
`“Drug-Induced Peptic Ulcer Disease,” Valerie Vella, Journal of
`the Malta College of Pharmacy Practice, Issue 10 (2005)
`
`“Goodman & Gilman’s The Pharmacological Basis of
`Therapeutics,” Joel G. Hardman, et al., McGraw-Hill Publ’g Co.,
`Ninth Edition (1996)
`
`“Upper Gastrointestinal (GI) pH in Young, Healthy Men and
`Women,” Jennifer B. Dressman, et al., Pharmaceutical Research,
`Vol. 7, No. 7 (July 1990)
`
`“Effect of Orally Administered Prostaglandin E2 and its 15-
`Methyl Analogues on Gastric Secretion,” S. M. M. Karim, et al.,
`British Med. Journal (Jan. 20, 1973)
`
`“Tagamet: The Discovery of Histamine H2-Receptor
`Antagonists,” SmithKlein Beecham Pharm., Am. Chem. Soc.
`(Nov. 24, 1997)
`
`“Inhibition of Gastric (H+ + K+)-ATPase by the Substituted
`Benzimidazole Picoprazole,” B. Wallmark, et al., Biochimica et
`Biophysica Acta, Vol. 728, Issue 1 (Sept. 2, 1983)
`
`U.S. Patent No. 4,255,431
`
`Notice of Final Determination, In re: Patent Term Extension for
`U.S. Patent No. 6,143,771
`
`“Drug Discovery: Practices, Processes, and Perspectives,” Jie
`Jack Li, et al., John Wiley & Sons (Apr. 3, 2013)
`
`“Prevention of the Gastrointestinal Adverse Effects of
`Nonsteroidal Anti-Inflammatory Drugs,” Gregor J.E. Brown, et
`al., Drug Safety, Vol. 21, Issue 6 (Dec. 21, 1999)
`
`U.S. Patent App. Pub. 2002/0045184 (“Chen”)
`
`U.S. Patent No. 5,698,225
`
`2
`
`

`
`
`
`Exhibit No. Description
`
`IPR2015-01718
`Patent 8,945,621
`
`
`1025
`
`1026
`
`1027
`
`1028
`
`1029
`
`1030
`
`1031
`
`1032
`
`1033
`
`1034
`
`1035
`
`1036
`
`“Management of NSAID-Related Gastrointestinal Mucosal
`Injury,” Adam F. Barrison, et al., Inflammopharmacology, Vol. 7,
`No. 3 (Sept. 1999)
`
`“Prevention of NSAID-Induced Gastroduodenal Ulcers,” A.
`Rostom, et al., Cochrane Database of Systematic Reviews, Issue 4
`(2002)
`
`“Abolition by Omeprazole of Aspirin Induced Gastric Mucosal
`Injury in Man,” T. K. Daneshmend, et al., Gut, Vol. 31, Issue 5
`(May 1990)
`
`U.S. Pat. No. 6,319,519
`
`“Remington’s Pharmaceutical Sciences,” Alfonso R. Gennaro, et
`al., Mack Publ’g Co., Seventeenth Edition, (1985) (“Remington”)
`
`U.S. Patent No. 6,365,184 (“Depui”)
`
`VIMOVO® (Naproxen and Esomeprazole Magnesium) Tablets,
`Horizon Pharma, http://www.horizonpharma.com/vimovo/ (last
`visited May 9, 2015)
`
`Shargel Walmart Receipts
`
`U.S. Patent No. 6,224,911
`
`Int’l Patent Pub. No. WO 01/19346
`
`“Pharmacology of Proton Pump Inhibitors,” Jai Moo Shin, et al.,
`Current Gastroenterology Reports, Vol. 10, Issue 6 (Dec. 2008)
`
`Orange Book Patent Data for: N022511, Product 001,
`ESOMEPRAZOLE MAGNESUM; NAPROXEN (VIMOVO)
`TABLET, DELAYED RELEASE EQ 20MG BASE; 500MG
`
`1037
`
`Deposition Transcript of David A. Johnson, M.D. (Aug. 27, 2016)
`
`3
`
`

`
`IPR2015-01718
`Patent 8,945,621
`
`
`Exhibit No. Description
`
`1038
`
`Deposition Transcript of Robert W. Makuch, Ph.D. (Sept. 19,
`2016)
`
`Respectfully submitted,
`
`
`
`
`
`/Amy E. LaValle/
`Amy E. LaValle (Reg. No. 51,092)
`Jerry C. Harris, Jr. (Reg. No. 66,822)
`WICK PHILLIPS GOULD & MARTIN, LLP
`3131 McKinney Avenue, Suite 100
`Dallas, TX 75204
`(214) 692-6200 (phone)
`(214) 692-6255 (fax)
`amy.lavalle@wickphillips.com
`jerry.harris@wickphillips.com
`
`Counsel for Petitioner
`Coalition for Affordable Drugs VII LLC
`
`Date: September 29, 2016
`
`
`
`
`
`
`
`
`
`4
`
`

`
`
`
`CERTIFICATE OF SERVICE
`
`IPR2015-01718
`Patent 8,945,621
`
`
`Pursuant to 37 C.F.R. § 42.6(e), I hereby certify that on September 29, 2016
`
`a copy of the foregoing PETITIONER’S UPDATED EXHIBIT LIST was provided
`
`via email to the following counsel of record for Patent Owner:
`
`Lead Counsel
`Ricardo Rodriguez
`COOLEY LLP
`3175 Hanover Street
`Palo Alto, CA 94304-1130
`Tel: (650) 843-5046
`Fax: (650) 843-7400
`rr@cooley.com
`zIPR2015-01718@cooley.com
`
`Back-Up Counsel
`Lauren L. Stevens, Ph.D.
`HORIZON PHARMA USA, INC.
`150 S. Saunders Road
`Lake Forest, Illinois 60045
`Tel: (224) 383-3265
`Fax: (224) 383-3001
`lstevens@horizonpharma.com
`
`Back-Up Counsel
`Stephen M. Hash, Ph.D.
`BAKER BOTTS LLP
`98 San Jacinto Blvd., Suite 1500
`Austin, TX 78701-4078
`Tel: (512) 322-2587
`Fax: (512) 322-3687
`stephen.hash@bakerbotts.com
`PozenVimovoBB@bakerbotts.com
`
`Back-Up Counsel
`Thomas A. Blinka, Ph.D.
`COOLEY LLP
`1299 Pennsylvania Avenue, NW
`Suite 700
`Washington, DC 20004-2400
`Tel: (202) 842-7800
`Fax: (202) 842-7899
`tblinka@cooley.com
`
`Back-Up Counsel
`Dennis Bennett
`GLOBAL PATENT GROUP, LLC
`1005 N. Warson Road, Suite 404
`St. Louis, MO 63132
`Tel: (314) 812-8018
`Fax: (314) 685-2300
`dennisbennett@globalpatentgroup.com
`
`Back-Up Counsel
`Margaret J. Sampson, Ph.D.
`BAKER BOTTS LLP
`98 San Jacinto Blvd., Suite 1500
`Austin, TX 78701-4078
`Tel: (512) 322-2552
`Fax: (512) 322-3652
`margaret.sampson@bakerbotts.com
`
`5
`
`

`
`IPR2015-01718
`Patent 8,945,621
`
`
`Back-Up Counsel
`Kevin Laurence
`RENAISSANCE IP LAW GROUP LLP
`1940 Duke Street, Second Floor
`Alexandria, VA 22314
`Tel: (703) 463-0640
`Fax: (503) 517-9919
`kevin.laurence@renaissanceiplaw.com
`
`
`
`
`
`
`/Amy E. LaValle/
`Lead Counsel for Petitioner
`Coalition for Affordable Drugs VII LLC
`
`
`
`
`Back-Up Counsel
`Jeffrey S. Gritton
`BAKER BOTTS LLP
`98 San Jacinto Blvd., Suite 1500
`Austin, TX 78701-4078
`Tel: (512) 322-2624
`Fax: (512) 322-3652
`Jeff.Gritton@bakerbotts.com
`
`Back-Up Counsel
`Matthew Phillips
`RENAISSANCE IP LAW GROUP LLP
`7327 SW Barnes Road #521
`Portland, OR 97225
`Tel: (503) 964-1129
`Fax: (503) 517-9919
`matthew.phillips@renaissanceiplaw.com
`
`
`
`Date: September 29, 2016
`
`
`
`6

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket